Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001193125-26-343079

President and CEO acquired 961 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Lamothe Jeffrey G. President and CEO 2026-08-06 Option exercise +961 961 D
Derivatives
Lamothe Jeffrey G. President and CEO 2026-08-06 Option exercise · Restricted Stock Unit −961 0 D
Loading xslF345X06/ownership.xml…